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Abstract 
Background: Patients with bipolar disorder (BD) are approximately twice as likely to die prematurely 
due cardiovascular diseases (CVD) than the general population. Cardiorespiratory fitness (CRF) is an 
important health outcome measure, predictive for CVD and premature mortality. 
Aims: The aim of the current study was to compare the CRF of outpatients with BD versus age-, 
gender-, and body mass index (BMI)-matched healthy controls (HC). A secondary aim was to assess 
potential correlates of CRF. 
Methods: All participants underwent a maximal incremental exercise test to measure the maximum 
oxygen uptake (VO2max, the golden standard assessment of cardiorespiratory fitness), wore a Body 
Sensewear Armband for 5 subsequent days to assess their physical activity behavior and completed 
the Positive-and-Negative-Affect-Schedule (PANAS). 
Results: Outpatients with BD (n=20; 47.8±7.6years) had a significantly lower VO2max compared with 
HC (n=20; 47.8±7.6years) (26.0±7.3 versus 30.4±6.5 ml/min/kg, P=0.047). A higher VO2max was 
correlated with younger age, higher active energy expenditure, higher PANAS positive and lower 
PANAS negative affect scores and a lower antipsychotic medication dose. 
Limitations: The limited sample and cross-sectional design preclude definitive conclusions.   
Conclusions: Compared with HC, outpatients with BD have reduced CRF levels of approximately 4.4 
ml/min/kg. In the general population such reductions are associated with a 20% increased premature 
mortality risk. Interventions targeting CRF in BD are required. Although more research is needed, 
clinicians should consider the utility of objective assessments of CRF for risk stratification in outpatient 
settings.  
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Introduction 
Metabolic and cardiovascular diseases (CVD) have become a major concern in patients with bipolar 
disorder (BD) (Prieto et al., 2014; Vancampfort et al., 2015a). Patients with BD are known to have 
nearly twice the normal risk of dying from CVD (Ösby et al., 2011, 2016). Genetic vulnerability 
(Ellingrod et al., 2012), illness-related inflammatory processes (Rosenblat et al., 2014), cardio-
metabolic side-effects of pharmacotherapy (Correll et al., 2015), and lifestyle factors including a 
sedentary lifestyle (Janney et al., 2014), higher prevalence of substance abuse (Waxmonsky et al., 
2005), and a poor diet (Bernstein et al., 2015) all contribute to the increased CVD risk.  
In the general population, cardiorespiratory fitness (the ability of the circulatory and respiratory 
systems to supply oxygen to working muscles during sustained physical activity) is a strong and 
independent predictor for CVD [relative risk (RR)=1.56; 95% confidence interval (CI)=1.39-1.75; 
p<0.001] and all-cause mortality (RR=1.70; 95%CI=1.51-1.92; P<0.001) (Kodama et al., 2009). Also in 
people with severe mental illness, cardiorespiratory fitness testing has important clinical implications 
and can be used to help guide the prescription of exercise programs (Vancampfort et al., 2015b). 
Since CVD risk factors are already prevalent in the early stages of BD, even during childhood and 
adolescence (Goldstein et al., 2015), physical activity and cardiorespiratory fitness assessment should 
be initiated as early as possible, in particular since adolescents with BD participate in vigorous 
exercise less frequently than other adolescents (Jewell et al., 2015) and experience less 
improvements in energy following exercise (Subramaniapillai et al., 2016).  
Previous cross-sectional research using submaximal fitness tests showed that, compared with 
body mass index (BMI)-, age- and gender matched healthy controls (HC), patients with BD have a 
reduced speed of limb movement, leg muscle strength and abdominal muscular endurance 
(Vancampfort et al., 2015c) and a reduced functional exercise capacity (Vancampfort et al., 2015d). 
Although submaximal fitness tests (i.e. tests were the maximal cardiorespiratory fitness is estimated 
based on, for example, the heart rate obtained) are safe, relatively easy to administer and 
inexpensive, they only evaluate the global and integrated responses of the cardiorespiratory, 
peripheral circulation and neuromuscular systems involved during submaximal exercise or functional 
activities (Vanhees et al., 2005). Submaximal fitness tests do not provide more specific diagnostic and 
prognostic information about the function of each of the different systems involved in exercise or about 
the mechanism of exercise limitation as is possible with maximal cardiopulmonary exercise testing 
(Vanhees et al., 2005). To date, data comparing cardiorespiratory fitness of patients with BD versus 
matched controls using maximal incremental exercise tests is absent.  Although a maximal 
incremental exercise test is more costly, needs highly specialized equipment, requires technical 
expertise to supervise and interpret the test and is more demanding for the patients, the maximal 
oxygen uptake (VO2max) assessed with a maximal incremental exercise test is the gold-standard to 
assess cardiorespiratory fitness (Vanhees et al., 2005). 
 Given the aforementioned, the aim of the current study was to compare the VO2max of 
patients with BD with BMI-, age- and gender-matched HC. A secondary aim was to assess potential 
correlates (physical activity energy expenditure, sedentary behavior, medication use, positive and 
negative affect) of VO2max. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods 
Participants and procedure 
Over a 10-month period, adult (18-65 years) outpatients with a DSM-5 diagnosis of BD (American 
Psychiatric Association, 2013) of the UPC KU Leuven campus Kortenberg in Belgium were invited to 
participate. Diagnoses were made by a psychiatrist using the Mini International Neuropsychiatric 
Interview (Sheehan et al., 1998). Patients with acute psychosis at the time of testing or a co-morbid 
DSM-5 diagnosis of substance abuse in the previous 6 months were excluded. Somatic exclusion 
criteria included evidence of severe cardiovascular, neuromuscular and endocrine disorders which 
according to the American College of Sports Medicine  (2009) might prevent safe participation in the 
study. Healthy control subjects were recruited among family and friends of the researchers who were 
blinded from the test results of the patient population. All healthy controls were volunteers who 
received a general physical examination in the previous year and reported to be free of significant 
cardiovascular, neuromuscular and endocrine disorders that might hinder safe participation. An 
independent statistician performed the matching for age, gender and body mass index (BMI). The 
study was approved by the Scientific and Ethical Committee of the UPC KU Leuven, campus 
Kortenberg, Belgium and conducted in accordance with the principles of the Declaration of Helsinki. All 
participants gave their written informed consent. Patients did not receive any compensation for study 
participation. 
 
Cardiorespiratory fitness: maximal incremental exercise testing  
Graded exercise tests were performed according to International accepted standards (Gibbons et al., 
2002) on a cycle ergometer (Siemens-Elema 380B; Ergometrics 800S, Ergometrics, Bitz, Germany) in 
an air-conditioned laboratory where the room temperature was regulated at 18-22°C. Participants 
were asked to cycle at a constant rate of 60 revolutions per minute. The initial workload of 20W was 
increased by 20W every minute. Blood pressure was measured at rest before the test, with the patient 
sitting on the bicycle, and every 2 minutes during graded exercise. Heart rate and a 12-lead 
electrocardiogram (Max Personal Exercise Testing
®
, Marquette, WI, USA) were registered 
continuously. In- and expired gasses were analyzed breath-by-breath by means of the Oxycon Pro 
(Jaeger, Mijnhardt, The Netherlands). The gas analyzers and the flow meter were calibrated before 
each test according to the manufacturer’s instructions. VO2max values were defined as the 30 
seconds average at the highest workload achieved. All participants were asked and encouraged to 
perform a symptom-limited graded exercise test until exhaustion. In order to define a maximal effect 
we followed the criteria described by the European Association for Cardiovascular Prevention and 
Rehabilitation (Mezzani et al., 2009). A maximal effort was assumed if the cardiopulmonary exercise 
testing was terminated by the patient due to exhaustion, dyspnea, pain or tiredness in the legs and if 
(1) a peak respiratory exchange ratio (RER) ≥1.10 and/or (2) a rating of perceived exertion ≥16 on the 
Borg Scale (Borg, 1998). 
 
Physical activity and sedentary behaviour: Sensewear Armband (SWA) 
All participants wore a Senswear armband (SWA) for five consecutive days, except when showering, 
bathing or swimming. The SWA was worn over the right arm triceps muscle and assessed minute to 
minute movement through multiple sensors, namely a two-axis accelerometer and sensors measuring 
heat flux, galvanic skin and near body-temperature. Data were combined with gender, age, body 
weight and height, to estimate active energy expenditure using algorithms developed by the 
manufacturer (SenseWear Professional software, version 7.0). As behavioral modification often occurs 
on the first day of monitoring (Corder et al., 2008), data recorded on the initial day were discounted 
entirely and only the data obtained during the subsequent 4 full days (including 2 weekdays and 2 
weekend days) were used. Several variables were calculated from the SWA data. Physical activity can 
be expressed in metabolic equivalents (MET; in kcal/hour/kg), an indicator of daily energy expenditure. 
The unit MET is used to estimate the amount of oxygen used by the body during physical activity. 
Daily average time spend in moderate (MPA) (3-6MET) and vigorous physical activity (VPA) (≥6MET) 
were calculated from all minutes with a MET-value (American College of Sports Medicine, 2009). 
Active energy expenditure (AEE; in kcals: ≥3MET) was calculated based on these 2 assessments. 
Next to this we also assessed the time spent sedentary (≤1.5MET). Data were accepted when the 
average on-body measuring time was at least 1368 minutes per day (95% of a 24-hour bout). The 
SWA has been validated in clinical (Van Remoortel et al., 2012) and non-clinical  (Reece et al., 2015) 
populations. 
 
 
 
Positive and negative affect 
The Positive-and-Negative-Affect-Schedule (PANAS) (Watson et al., 1988) is a 20-item questionnaire 
assessing positive and negative affect and was chosen as a measure of daily mood. Internationally, 
this instrument has received empirical support in the general population for its validity (e.g., Schmukle 
et al., 2002).  
 
Smoking behavior 
Participants were asked whether they smoked or not, and if so, how many cigarettes they smoked per 
day on average during the previous week. 
 
Anthropometric assessments 
Anthropometric measurements included body weight and height. Body weight was measured in light 
clothing to the nearest 0.1 kg using a SECA beam balance scale, and height to the nearest 0.1 cm 
using a wall-mounted stadiometer.  
 
Medication use 
Data on current use of antidepressants, mood stabilizers and antipsychotics was collected by checking 
the medical records. Daily dosage of each antipsychotic was converted into a daily equivalent dosage 
of chlorpromazine following the consensus of Gardner et al. (2010). If patients were treated with a 
combination of antipsychotics, all obtained equivalent dosages of chlorpromazine were summed 
together.  
 
Statistical analysis 
Data were assessed for normality using the Shapiro-Wilk test and found to be normally distributed. 
Descriptive statistics are therefore presented as mean ± standard deviation (SD). Unpaired t-tests or 
Mann-Whitney U tests were used, when appropriate, to examine differences in characteristics 
between outpatients with BD and HC. Relationships between variables were calculated using Pearson 
correlation coefficients. A backward regression analysis was conducted in order to determine the 
variance explained in VO2max. In order to prevent overfitting we only included significant correlates 
from the univariate tests (and only if the variable was available for all participants) in the model. To test 
for multicollinearity, a variance inflation factor was computed for each independent variable in the 
model. Values above 3 were used to indicate a multicollinearity problem in the model (Kleinbaum et 
al., 2013). A priori, a two sided level of significance was set at P≤0.05. Statistical analyses were 
performed using the statistical package SPSS version 23.0 (SPSS Inc., Chicago, IL). 
 
Results 
Participants 
A total of 28 outpatients with BD agreed to participate in the study. Three patients with co-morbid 
substance abuse during the previous six months were excluded. Two more were excluded as a 
consequence of a cardiovascular or neuromuscular disorder that might prevent safe participation. Of 
the 23 eligible patients with BD, three declined to participate (i.e., were not interested anymore). None 
of the included patients dropped-out or were unable to complete the tests and twenty patients were 
included in the final analysis. Twenty HC, matched for age, BMI and gender completed the maximal 
incremental test, the PANAS and worn the SWA. Participants’ characteristics are shown in Table 1. In 
both groups there were 6 men and 14 women. Two outpatients with BD smoked (10 and 20 cigarettes 
per day) compared to one of the HC (10 cigarettes per day). Ten patients were on antipsychotic 
medication (mean dose in chlorpromazine equivalents=367±217mg/day) while nine patients took 
lithium carbonate (mean dose=755±292mg/day) and eight patients were in receipt of lamotrigine 
(mean dose=225±128mg/day). Five patients took antidepressants: escitalopram (n=2), venlafaxine 
(n=1), sertraline (n=1), trazodone (n=1). Somatic medication was taken by 9 patients. None were on 
beta-blockers.  
[Add Table 1 about here] 
 
 
 
Differences in clinical characteristics between outpatients with bipolar disorder and matched healthy 
controls 
Outpatients with BD had a significantly (P=0.047) lower VO2max (26.0±7.3 versus ml/min/kg) 
compared to HC (30.4±6.5ml/min/kg, P=0.047).  Patients with BD also reported significantly higher 
Borg scores of perceived exertion during the test (P=0.039). While outpatients with BD were not 
significantly less physically active (P=0.42), they were more sedentary (P=0.001). The average on 
body time of the SWA was 96.7% (range: 95.1%-99.9%) for outpatients with BD and 99.1% (96.7%-
99.9%) for HC. Outpatients with BD scored significantly lower on the PANAS positive affect (P=0.015) 
score. Details are presented in Table 1. 
 
Correlates of VO2max in patients with BD 
Full details of the correlates with the obtained VO2max scores of outpatients with BD are summarized 
in Table 2. Briefly, higher VO2max score were significantly correlated with younger age, higher levels 
of active energy expenditure, higher PANAS positive affect and lower PANAS negative affect scores 
and a lower antipsychotic medication dose. There was also trend (P=0.057) for a lower VO2max in 
those patients taking antipsychotic medication (22.9±6.9 versus 29.0±6.7 ml/min/kg). Patients taking 
antipsychotic medication were also significantly less physically active (mean active energy 
expenditure=510.6±301.0 versus 791.3±272.7 kcal/day) There were no other significant clinical 
differences between both groups. Although male patients with BD had a higher VO2max than female 
patients (28.7±4.6 versus 24.7±8.1 ml/min/kg), this difference was not significant (P=0.18). 
[Add Table 2 about here] 
 
All significant correlates which were available in all outpatients with BD (i.e. age, active energy 
expenditure, PANAS positive and negative affect) were included in a backward regression analysis. 
Within the fully adjusted VO2max-model, the unique significant predictors of a higher VO2max score 
were younger age and higher PANAS positive affect scores. The model explained 71.6% of the 
variance in the VO2max -score. Details of the final model are presented in Table 3. 
[Add Table 3 about here] 
 
 
 
Tolerability in outpatients with BD 
Termination reason in BD was muscular soreness (n=9, 45%), shortness of breath (n=2, 10%), and 
physical fatigue (n=9, 45%). No patient with BD terminated the test due to exercise-induced rhythm 
abnormalities or other clinical symptoms warranting premature ending of the test.  
Discussion 
General findings  
To the authors’ knowledge, the present preliminary study is the first to compare the cardiorespiratory 
fitness using a maximal incremental exercise test in outpatients with BD with age, gender and BMI-
matched HC. Our preliminary data suggest that outpatients with BD have a significantly reduced 
VO2max, which is the gold-standard for assessing a person’s cardiorespiratory fitness level. The mean 
difference in cardiorespiratory fitness is approximately -4.4ml/min/kg. Such a reduction is clinically 
important as in the general population each reduction of 3.5 ml/kg/min in VO2max increases the 
hazard ratio for premature CVD mortality with more than 20% higher while the hazard ratio for all-
cause mortality increases with15% in men and 8% in women (Nes et al., 2014).  
 Our data also demonstrate that next to age, higher active energy expenditure levels, lower 
antipsychotic medication doses, higher positive affect and lower negative affect levels might be 
associated with higher cardiorespiratory fitness levels. More research is however needed to explore all 
these possible determinants. Although the antipsychotic medication dose might be a measure-of-proxy 
for the presence and level of psychotic symptoms, acute psychosis at the time of the testing was an 
exclusion criterion. To the best of our knowledge, studies exploring the effect of antipsychotics but also 
of mood stabilizers on cardiorespiratory parameters is currently absent in the literature and should 
become a research priority. Future research should in particular explore the effect of mood symptoms 
on the level of cardiorespiratory fitness. A more positive affect might be associated with higher levels 
of self-efficacy, a more active lifestyle, more motivation to perform well, and less negative outcome 
expectations which on their turn might be associated with better physical fitness test performances. In 
the opposite way, a more negative affect might be associated with lower levels of self-efficacy, a more 
sedentary lifestyle, and less motivation to perform well which on their turn might be associated with 
worse physical fitness test performances. Outpatients with BD perceived the exercise tests as more 
exhausting on the Borg scale than HC. Also the low-grade inflammation associated with mood 
fluctuations (Leboyer et al., 2012) might be a hypothesis which should be tested more in detail. 
Inflammatory processes may cause pathological microvascular changes that can affect gas transfer 
across the alveolar-capillary membrane, which in turn may affect the circulatory, respiratory, and 
muscular systems involved in supplying oxygen to the body (Ostermann et al., 2012). Finally, future 
research should explore in more detail the role of physical activity and a sedentary lifestyle. One 
should note that in our exploratory analysis higher levels of sedentary behavior per day was not 
associated with lower cardiorespiratory fitness levels. It might be hypothesized that the time spent 
actively at moderate to high intensity will most directly influence the cardiorespiratory fitness, however 
an increased time spent in sedentary activities is related with worsening of several cardio-metabolic 
functions, and might eventually also negatively influence cardiorespiratory fitness. Longitudinal and 
interventional studies are therefore needed to explore more rigorously the role of physical activity and 
a sedentary lifestyle on cardiorespiratory fitness levels in outpatients with BD. Recent meta-analyses 
in patients with schizophrenia (Vancampfort et al., 2015e) and major depressive disorder (Stubbs et 
al., 2016) clearly demonstrate that patients with severe mental illness can achieve clinically relevant 
improvements in cardiorespiratory fitness in response to exercise interventions. 
 
Practical implications 
Low cardiorespiratory fitness, as measured by maximal cardiorespiratory exercise testing, is a potent 
predictor of CVD and premature all-cause mortality (Kodama et al., 2009) and even a stronger 
predictor than traditional risk factors such as overweight, dyslipidemia, high blood pressure, and 
smoking (Myers et al., 2002). In addition, a single measurement of CRF considerably improves risk 
classification beyond traditional risk factors (Gupta et al., 2011). As outpatients with BD have impaired 
cardiorespiratory fitness levels, the objective assessment of cardiorespiratory fitness (i.e., by 
ventilatory gas analysis) is an appealing approach for risk stratification in outpatient settings.  
 
Limitations 
The present findings need to be interpreted with caution because of some methodological limitations. 
Firstly, the study is a pilot with a limited sample size and included volunteers and our results should be 
considered with this in mind. Moreover, due to the inclusion of volunteers our data may overestimate 
the cardiorespiratory fitness level in outpatients with BDs and in HC. Nevertheless, there was a good 
response rate in the BD group which should prevent serious distortion of the results due to selection 
bias. Although in the healthy controls’ group SWA scores were in agreement with a large-scale 
Belgian general population study (Scheers et al., 2013), a selection bias in favor of healthier control 
volunteers cannot be excluded. Second, most outpatients were on poly-pharmacy making it impossible 
to investigate the role of specific medications on the cardiorespiratory fitness level. Third, we did not 
collect data on physical activity and sedentary behavior in the weeks prior to the testing, any physical 
comorbidities nor on mental health parameters such as comorbid anxiety, motivational level and 
number of previous bipolar episodes. BD is uniquely characterized by instability, mood and activity 
fluctuations, course variability and unpredictability, ongoing symptoms and ongoing fluctuations, even 
during the remitted phase, disruption of circadian rhythms that may all be part of a common diathesis 
that may lead to a reduced ability to perform daily life activities (Frank et al., 2000). Future research in 
patients with BD should explore the role of these parameters, including a rigorous assessment of 
manic and depressive symptoms, on the cardiorespiratory fitness level. Future research should also 
explore the role of cardio-metabolic risk factors such as hypertension and abdominal obesity on the 
cardiorespiratory fitness level of people with BD. Fourth, our data are cross-sectional and cannot 
establish cause and effect. Nevertheless, our study is the first to establish that outpatients with BD 
have a reduced cardiorespiratory fitness level compared with age-, gender- and BMI-matched 
controls. Future larger scale research is required to replicate our study in order to establish if our 
results are generalizable to other populations of patients with BD in other settings and countries.   
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Table 1. Comparisons in baseline characteristics between outpatients with bipolar disorder and 
healthy controls 
Data expressed as mean ± standard deviation, BMI = body mass index, VO2max= maximum oxygen 
uptake, SWA AEE= Sensewear armband active energy expenditure, PANAS= Positive and Negative 
Affect Schedule, *significant when P≤0.05. 
 
 
 
 
 
 
 
 
 
Variables Bipolar disorder 
(n=20) 
Healthy controls 
(n=20) 
P 
Gender (men/women) 6/14 6/14 1.0 
Age (years) 47.9±7.9 47.8±7.6 0.95 
BMI (kg/m²) 26.4±5.2 25.6±5.0 0.60 
VO2max (ml/min/kg) 26.0±7.3 30.4±6.5 0.047* 
Borg score 17.2±1.1 16.3±1.5 0.039* 
SWA AEE (kcal/day) 650.9±314.5 731.2±306.0 0.42 
SWA sedentary time (min/day) 1062.4±136.2 898.2±161.8 0.001* 
PANAS positive affect (0-50) 30.5±9.1 36.9±6.8 0.015* 
PANAS negative affect (0-50) 19.9±8.1 15.4±7.4 0.072 
Table 2. Associations of the maximum oxygen uptake (VO2max) with demographical and clinical 
variables in outpatients with bipolar disorder (n=20) 
Data expressed as mean ± standard deviation, BMI = body mass index, SWA AEE= Sensewear 
armband active energy expenditure, PANAS = Positive and Negative Affect Schedule, *significant 
when P≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables Pearson’s r P 
Age (years) -0.66 0.002* 
BMI (kg/m²) -0.64 0.002* 
SWA AEE (kcal/day) 0.63 0.003* 
SWA sedentary time (min/day) -0.24 0.31 
PANAS positive affect (0-50) 0.78 0.001* 
PANAS negative affect (0-50) -0.60 0.005* 
Chlorpromazine equivalent (mg/day) -0.64 0.044* 
 
 
 
Table 3. Backward stepwise regression analysis with the maximum oxygen uptake (VO2max) as 
dependent variable (final model)  
°Significant correlates (i.e. age, active energy expenditure, PANAS positive and negative affect and 
SF-36 physical and psychological subcomponents) were included in the models, B=unstandardized 
coefficient, SE = standard error, β=standardized coefficient, VIF = variance inflation factor, PANAS= 
Positive and Negative Affect Scale, *significant when P≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highlights 
 Outpatients with bipolar disorder have a lower cardiorespiratory fitness than healthy controls. 
 Maximal incremental exercise tests are safe and well tolerated by outpatients with bipolar 
disorder. 
 Future research should explore the role of mood symptoms and antipsychotics on fitness levels. 
 
 
 
 
Variables° B SE β t VIF P 
(Constant) 27.7 9.1  3.0  0.007* 
Age -0.3 0.1 -0.4 -2.4 1.3 0.024* 
PANAS positive affect 0.5 0.1 0.6 4.0 1.3 0.001* 
